Veterinary Medicines

Amoxy Active, 697 mg/g oral powder for pigs and chickens

Authorised
  • Amoxicillin trihydrate
Download as PDF

Product identification

Medicine name:
Amoxy Active, 697 mg/g oral powder for pigs and chickens
AMOXY ACTIVE 697 mg/g, πόσιμη κόνις για χοίρους και ορνίθια
Active substance:
  • Amoxicillin trihydrate
Target species:
  • Chicken
  • Pig
Route of administration:
  • In drinking water use
  • In-feed use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    800.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        1
        day
    • Pig
      • Meat and offal
        2
        day
  • In-feed use
    • Chicken
      • Meat and offal
        1
        day
    • Pig
      • Meat and offal
        2
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CA04
Legal status of supply:
  • Medicinal product subject to medical prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • 500 g Securitainer: white polypropylene container , covered with a low-density polyethylene lid.
  • 5 kg Bucket: white polypropylene bucket provided with a polypropylene lid.
  • 250 g Securitainer: white polypropylene container , covered with a low-density polyethylene lid.
  • 2,5 kg Bucket: white polypropylene bucket provided with a polypropylene lid.
  • 100 g Securitainer: white polypropylene container , covered with a low-density polyethylene lid.
  • 1 kg Securitainer: white polypropylene container , covered with a low-density polyethylene lid.
  • 1 kg Bucket: white polypropylene bucket provided with a polypropylene lid.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dopharma Research B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dopharma B.V.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 96893/18 / 10-06-2019 / Κ-0203601
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0179/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 28/09/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."